3

PRIMARY DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: January 18, 2013
Period of Report: December 28, 2012
Accession Number: 0001188112-13-000128

View Document ↗ View on SEC.gov ↗